Forte Biosciences, Inc. · NASDAQ:FBRX
Ikarian Capital, LLC reported a 9.50% stake in Forte Biosciences, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Ikarian Capital, LLC reported a 9.50% stake in Forte Biosciences, Inc., 609,225 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 9.50%
- Shares
- 609,225
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.50% | 609,225 |
| Neil Shahrestani | 9.50% | 609,225 |
Source
Related
- Forte Biosciences, Inc.
- Ikarian Capital, LLC
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026